A tool kit for rapid cloning and expression of recombinant antibodies

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Dodev, Tihomir S ^a,d   Karagiannis, Panagiotis ^a,b   Gilbert, Amy E ^a,b   Josephs, Debra H ^a,b,c   Bowen, Holly ^a,d   James, Louisa K ^d   Bax, Heather J ^d   Beavil, Rebecca ^d   Pang, Marie O ^d   Gould, Hannah J ^d   Karagiannis, Sophia N ^a,b   Beavil, Andrew J ^d  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; DIAGNOSTIC KIT; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; PHL P 7 ALLERGEN; PLANT ANTIGEN; PRIMER DNA; VEGETABLE PROTEIN;

ANIMAL; BIOSYNTHESIS; CHEMISTRY; DIAGNOSTIC KIT; ESCHERICHIA COLI; GENE EXPRESSION; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROCEDURES; SYNTHESIS;

ANIMALS; ANTIGENS, PLANT; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CLONING, MOLECULAR; DNA PRIMERS; EPITOPES; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MOLECULAR SEQUENCE DATA; PLANT PROTEINS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RECOMBINANT FUSION PROTEINS;

EID: 84905235521     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05885     Document Type: Article

References (46)

1. Buss, N. A., Henderson, S. J., McFarlane, M., Shenton, J. M. & de Haan, L. Monoclonal antibody therapeutics: history and future. Curr Opin Pharmacol 12, 615-622, doi:10.1016/j.coph.2012.08.001 (2012).
2. Singer, J. & Jensen-Jarolim, E. IgE-based immunotherapy of cancer: challenges and chances. Allergy 69, 137-149, doi:10.1111/all.12276 (2014).
3. Woof, J. M. Insights from Fc receptor biology: a route to improved antibody reagents. mAbs 4, 291-293, doi:10.4161/mabs.20100 (2012).
4. Thakkar, S., Nanaware-Kharade, N., Celikel, R., Peterson, E. C. & Varughese, K. I. Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering. Sci. Rep. 4, 3673, doi:10.1038/srep03673 (2014).
5. Foreman, A. L., Van de Water, J., Gougeon, M. L. & Gershwin, M. E. B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev 6, 387-401, doi:10.1016/j.autrev.2006.12.005 (2007). (Pubitemid 46824095)
6. Snow, R. E., Chapman, C. J., Frew, A. J., Holgate, S. T. & Stevenson, F. K. Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. J Immunol 154, 5576-5581 (1995).
7. Snow, R. E., Chapman, C. J., Frew, A. J., Holgate, S. T.&Stevenson, F. K. Pattern of usage and somatic hypermutation in the V(H)5 gene segments of a patient with asthma: implications for IgE. Eur J Immunol 27, 162-170, doi:10.1002/eji.1830270124 (1997). (Pubitemid 27046073)
8. Janezic, A. et al. Immunogenetic analysis of the heavy chain variable regions of IgE from patients allergic to peanuts. J Allergy Clin Immunol 101, 391-396, doi: 10.1016/S0091-6749(98)70253-2 (1998). (Pubitemid 28146360)
9. Coker, H. A., Durham, S. R. & Gould, H. J. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 171, 5602-5610, doi: 10.4049/jimmunol.171.10.5602 (2003). (Pubitemid 37432852)
10. Coker, H. A. et al. Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis. J Allergy Clin Immunol 116, 445-452, doi:10.1016/j.jaci.2005.04.032 (2005). (Pubitemid 41096557)
11. Snow, R. E., Djukanovic, R. & Stevenson, F. K. Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 98, 646-651, doi:910 (1999). (Pubitemid 30005349)
12. James, L. K. et al. Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy. J Allergy Clin Immunol 130, 663-670 e663, doi:10.1016/j.jaci.2012.04.006 (2012).
13. Bende, R. J., Aarts, W. M., Pals, S. T. & van Noesel, C. J. Immunoglobulin diversification in B cell malignancies: internal splicing of heavy chain variable region as a by-product of somatic hypermutation. Leukemia 16, 636-644, doi:10.1038/sj.leu.2402405 (2002). (Pubitemid 34449745)
14. Küppers, R., Hajadi, M., Plank, L., Rajewsky, K. & Hansmann,M.-L. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human. Eur J Immunol 26, 1794-1800, doi:10.1002/eji.1830260820 (1996). (Pubitemid 26283153)
15. Tobin, G. The immunoglobulin genes and chronic lymphocytic leukemia (CLL). Ups J Med Sci 110, 97-113 (2005). (Pubitemid 40880479)
16. Tobin, G., Rosen, A. & Rosenquist, R. What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia? Hematol Oncol 24, 7-13, doi:10.1002/hon.760 (2006).
17. Volkheimer, A. D. et al. Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification. Blood 109, 1559-1567, doi:10.1182/blood-2006-05-020644 (2007). (Pubitemid 46239589)
18. Hoogenboom, H. R. Selecting and screening recombinant antibody libraries. Nat Biotechnol 23, 1105-1116, doi:10.1038/nbt1126 (2005). (Pubitemid 41486392)
19. Bebbington, C. R. et al. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (N Y) 10, 169-175 (1992).
20. Filpula, D. Antibody engineering and modification technologies. Biomol Eng 24, 201-215, doi:10.1016/j.bioeng.2007.03.004 (2007). (Pubitemid 46755015)
21. Jain,M., Kamal, N. & Batra, S. K. Engineering antibodies for clinical applications. Trends Biotechnol 25, 307-316, doi:10.1016/j.tibtech.2007.05.001 (2007). (Pubitemid 46899246)
22. Jones, D. et al. High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19, 163-168, doi:10.1021/bp025574h (2003). (Pubitemid 36219317)
23. Maynard, J. & Georgiou, G. Antibody engineering. Annu Rev Biomed Eng 2, 339-376, doi:10.1146/annurev.bioeng.2.1.339 (2000).
24. Zafir-Lavie, I., Michaeli, Y. & Reiter, Y. Novel antibodies as anticancer agents. Oncogene 26, 3714-3733, doi:10.1038/sj.onc.1210372 (2007). (Pubitemid 46842707)
25. Koelsch, K. et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest 117, 1558-1565, doi:10.1172/JCI27628 (2007). (Pubitemid 46871340)
26. Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 4, 372-384, doi:10.1038/nprot. 2009.3 (2009).
27. Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112-124, doi:10.1016/j.jim.2007.09.017 (2008). (Pubitemid 350235462)
28. Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667-671, doi:10.1038/nature06890 (2008). (Pubitemid 351769295)
29. Braren, I. et al. Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries. Clin Chem 53, 837-844, doi:10.1373/clinchem.2006.078360 (2007). (Pubitemid 46744238)
30. Hecker, J. et al. Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the Timothy grass major allergen Phl p 5a. Mol Immunol 48, 1236-1244, doi:10.1016/j.molimm.2011.03.005 (2011).
31. Wiberg, F. C. et al. Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Biotechnol Bioeng 94, 396-405, doi:10.1002/bit.20865 (2006). (Pubitemid 43799538)
32. Klock, H. E., Koesema, E. J., Knuth, M. W. & Lesley, S. A. Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts. Proteins 71, 982-994, doi:10.1002/prot.21786 (2008). (Pubitemid 351430029)
33. Hunt, J. et al. Disulfide linkage controls the affinity and stoichiometry of IgE Fcepsilon3-4 binding to FcepsilonRI. J Biol Chem 280, 16808-16814, doi:10.1074/jbc.M500965200 (2005). (Pubitemid 41389139)
34. Karagiannis, S. N. et al. Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol 33, 1030-1040, doi:10.1002/eji.200323185 (2003). (Pubitemid 36546691)
35. Dibbern, D. A., Jr., Palmer, G. W.,Williams, P. B., Bock, S. A. & Dreskin, S. C. RBL cells expressing human Fc epsilon RI are a sensitive tool for exploring functional IgE-allergen interactions: studies with sera from peanut-sensitive patients. J. Immunol. Methods 274, 37-45 (2003). (Pubitemid 36263041)
36. Olsen, D. B. & Eckstein, F. Incomplete primer extension during in vitro DNA amplification catalyzed by Taq polymerase; exploitation for DNA sequencing. Nucleic Acids Res 17, 9613-9620 (1989). (Pubitemid 20010771)
37. Tiller, T., Busse, C. E. & Wardemann, H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350, 183-193, doi:10.1016/j.jim.2009.08.009 (2009).
38. Liao, H. X. et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 158, 171-179, doi:10.1016/j.jviromet.2009.02.014 (2009).
39. Karagiannis, P. et al. Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunol Immunother 58, 915-930, doi:10.1007/s00262-008-0607-1 (2009).
40. Natali, P. G., Bigotti, A., Cavaliere, R., Nicotra, M. R. & Ferrone, S. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J. Natl. Cancer Inst. 73, 13-24 (1984). (Pubitemid 14090824)
41. Karagiannis, P. et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest, doi:10.1172/JCI65579 (2013).
42. Sundstrom, C. & Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17, 565-577 (1976).
43. Giard, D. J. et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417-1423 (1973).
44. Graham, F. L., Smiley, J., Russell, W. C.& Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74 (1977).
45. McCloskey, N. et al. Soluble CD23monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J Biol Chem 282, 24083-24091, doi:10.1074/jbc.M703195200 (2007). (Pubitemid 47328009)
46. Schwartz, W. et al. Application of Chemically-Stable Immunoglobulin- Selective Sorbents: Capture and Purification of Antibodies with Resolution of Aggregate. BioProcessing 3, 53-62 (2004).